Health Care & Life Sciences » Pharmaceuticals | Biofil Chemicals & Pharmaceuticals Ltd.

Biofil Chemicals & Pharmaceuticals Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
1,835.10
1,318.20
2,808.10
3,107.80
3,745.10
1,361.80
Total Accounts Receivable
41,041.10
36,512.20
139,846.30
114,644.10
129,808.20
120,250.10
Inventories
2,735.70
1,664.50
960.20
1,663.00
10,248.40
11,909.20
Other Current Assets
8,642.20
7,491.30
7,949.40
7,343.70
5,275.90
5,667.20
Total Current Assets
54,254.00
46,986.30
151,564.10
126,758.60
149,077.60
139,188.20
Net Property, Plant & Equipment
91,732.60
90,576.50
89,755.30
91,645.30
92,468.40
102,942
Other Assets
-
-
-
-
0.10
-
Total Assets
145,986.70
137,562.80
241,319.40
218,403.90
241,546.10
242,130.20
ST Debt & Current Portion LT Debt
28,705.20
29,800.60
13,699.80
14,280.90
15,585.50
Accounts Payable
36,357.70
21,109.00
115,918.50
70,952.20
91,416.90
Income Tax Payable
1,239.70
1,425.60
1,924.00
5,517.10
-
Other Current Liabilities
1,054.90
1,080.00
709.60
688.10
2,871.10
Total Current Liabilities
67,357.50
53,415.20
132,251.80
91,438.40
109,873.50
Other Liabilities
-
-
-
-
0.10
Total Liabilities
67,357.50
53,415.20
132,251.80
91,438.40
109,873.60
Common Equity (Total)
78,129.20
83,647.70
108,567.60
126,465.50
131,672.50
Total Shareholders' Equity
78,129.20
83,647.70
108,567.60
126,465.50
131,672.50
Total Equity
78,129.20
83,647.70
108,567.60
126,465.50
131,672.50
Liabilities & Shareholders' Equity
145,986.70
137,562.80
241,319.40
218,403.90
241,546.10
Non-Equity Reserves
500.00
500.00
500.00
500.00
-

About Biofil Chemicals & Pharmaceuticals

View Profile
Address
11/12, Sector E, Sanwer Road
Indore Madhya Pradesh 452015
India
Employees -
Website http://www.biofilgroup.net
Updated 07/08/2019
Biofil Chemicals & Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical products. The company products include basic drugs and chemicals, and plastic dripper and caps. It operates through the following segments: Pharmaceuticals, Chemicals, and Plastic.